caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1861498271

Marwan FakihMD

PRACTICECITY OF HOPESee all providers at this practice →
Medical OncologyDuarte, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Marwan Fakih's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Jimmie Wong
Diagnostic Radiology · Duarte, CA
40254
Julie Ressler
Diagnostic Radiology · Duarte, CA
30238
MARX, HOWARD29163
SHAW, SARA28179
Ko Yamada
Cardiology · Los Angeles, CA
25222
SENTOVICH, STEPHEN24689
Alexander Jung
Diagnostic Radiology · Duarte, CA
22142
ROTTER, ARNOLD21171
Unilab Corporation
Clinical Laboratory · West Hills, CA
20142
PARK, JOHN14106
Eduardo Siccion
Internal Medicine · La Verne, CA
12105
Yuman Fong
Surgical Oncology · Duarte, CA
11276
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
410
Unique beneficiaries
—
Total services
896
Distinct HCPCS
4
Medicare payment
$88K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 268 Medical Oncology providers in CA — below median (cohort median 1,130).
PRESCRIBING · PART D · 2024
Total Rx claims
166
Beneficiaries
—
Total drug cost
$608K
Distinct drugs
7
Brand share
40.4%
Top prescribed drugs
Trifluridine/Tipiracil Hcl42 claims
Dexamethasone35 claims
Ondansetron Hcl35 claims
Doxycycline Hyclate16 claims
0.9 % Sodium Chloride13 claims
QUALITY · MIPS · 2024
Final MIPS score
92.8
Quality
78.5
Cost
70.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.75%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$33K
Payment records
42
By payment type
Consulting Fee$22K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$7K
Travel and Lodging$3K
Food and Beverage$969
Education$18